Japan ramps up patent effort to keep iPS lead

David Cyranoski

Nature, 2008, vol. 453, issue 7198, 962-963

Abstract: United States in race to commercialize pluripotent stem cells.

Date: 2008
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/453962a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:453:y:2008:i:7198:d:10.1038_453962a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/453962a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().